JB

Joseph Baron

General Partner at Extera Partners

Cambridge, Massachusetts

Invests in

Locations:

  • Min Investment:

    $50,000.00
  • Max Investment:

    $300,000.00
  • Target Investment:

    $100,000.00

Education

Work Experience

  • Board Member and Start-Up CEO

    2010

    Janus Biotherapeutics is an autoimmunity therapeutics company dedicated to the development of novel, orally available compounds for the treatment of autoimmune diseases including systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome, psoriasis, and scleroderma.

  • General Partner

    2007

    Extera Partners is a global life science strategic and transaction advisory firm that specializes in planning for and executing strategic partnerships, acquisitions, and new product commercialization.

2003 - 2006

  • Principal

    2003 - 2006

1999 - 2001

  • Team Leader

    1999 - 2001

1994 - 1998

  • Associate

    1994 - 1998